These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27442379)

  • 21. Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants.
    Alloway RR; Isaacs R; Lake K; Hoyer P; First R; Helderman H; Bunnapradist S; Leichtman A; Bennett MW; Tejani A; Takemoto SK
    Am J Transplant; 2003 Oct; 3(10):1211-5. PubMed ID: 14510694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients.
    Choi HJ; Kim DG; Kwak BJ; Han JH; Hong TH; You YK
    Drug Des Devel Ther; 2018; 12():295-301. PubMed ID: 29483770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generic maintenance immunosuppression in solid organ transplant recipients.
    Ensor CR; Trofe-Clark J; Gabardi S; McDevitt-Potter LM; Shullo MA
    Pharmacotherapy; 2011 Nov; 31(11):1111-29. PubMed ID: 22026398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
    Lazzaro C; McKechnie T; McKenna M
    J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressive regimens containing generic mycophenolate mofetil (Myfenax) in de novo renal transplant recipients--preliminary results of 6-month observation.
    Rutkowski B; Bzoma B; Dębska-Ślizień A; Chamienia A
    Ann Transplant; 2011; 16(4):74-80. PubMed ID: 22210425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effective immunosuppressive options for solid organ transplantation: a guide to lower cost for the renal transplant recipient in the USA.
    Farney AC; Doares W; Kaczmorski S; Rogers J; Stratta RJ
    Immunotherapy; 2010 Nov; 2(6):879-88. PubMed ID: 21091118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The generics in transplantation and the rules on their use.
    Masri M
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generic immunosuppressants in hematopoietic cell transplantation.
    Cutler C; Kesselheim A; Gabardi S; Andersson BS; Carpenter P; Khoury HJ; Litzow M; Rowley SD; Lanum S; Leather H; Tina Shih YC; Gale RP; Wingard JR; Appelbaum FR; Anasetti C;
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):285-90. PubMed ID: 21087678
    [No Abstract]   [Full Text] [Related]  

  • 29. Generic medicines in the Malaysian health care system: Opportunities and challenges.
    Wong ZY; Alrasheedy AA; Hassali MA; Saleem F
    Res Social Adm Pharm; 2016; 12(5):807-10. PubMed ID: 27157864
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of Systematic Conversion to Generic Mycophenolate Mofetil (MMF) in Kidney Transplantation: A Single-Center Clinical Experience from Japan.
    Hirano H; Matsunaga T; Maenosono R; Taniguchi S; Uehara H; Nomi H; Kano Y; Fujiwara Y; Ichihashi A; Kobayashi D; Tsutsumi T; Komura K; Ibuki N; Inamoto T; Matsumura H; Ashida A; Azuma H
    Transplant Proc; 2018 Dec; 50(10):3255-3257. PubMed ID: 30577194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up.
    Dannhorn E; Cheung M; Rodrigues S; Cooper H; Thorburn D; Patch D; Burroughs AK; O'Beirne J
    Clin Transplant; 2014 Dec; 28(12):1349-57. PubMed ID: 25142496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring.
    Melilli E; Crespo E; Sandoval D; Manonelles A; Sala N; Mast R; Padulles A; Grinyo JM; Bestard O; Cruzado JM
    Transpl Int; 2015 Nov; 28(11):1283-90. PubMed ID: 26088437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results.
    Abdallah TB; Ounissi M; Cherif M; Helal I; Karoui C; Mhibik S; Bacha MM; Abderrahim E; Kheder A
    Exp Clin Transplant; 2010 Dec; 8(4):292-6. PubMed ID: 21143094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of generics in transplantation: Towards rational and safe solutions!].
    Rottembourg J; Rostoker G
    Presse Med; 2018 Mar; 47(3):199-210. PubMed ID: 29555162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation.
    Manzia TM; Angelico R; Toti L; Angelico C; Quaranta C; Parente A; Blasi F; Iesari S; Sforza D; Baiocchi L; Lerut J; Tisone G
    Liver Transpl; 2018 Sep; 24(9):1199-1208. PubMed ID: 30129171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generic formulation of mycophenolate mofetil (Myfenax) in de novo renal transplant recipients: results of 12-month observation.
    Rutkowski B; Bzoma B; Dębska-Ślizień A; Chamienia A
    Transplant Proc; 2014 Oct; 46(8):2683-8. PubMed ID: 25380894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001.
    Pollard S; Nashan B; Johnston A; Hoyer P; Belitsky P; Keown P; Helderman H;
    Clin Ther; 2003 Jun; 25(6):1654-69. PubMed ID: 12860490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic impact of the introduction of machine perfusion preservation in a kidney transplantation program in the expanded donor era: cost-effectiveness assessment.
    Gómez V; Galeano C; Diez V; Bueno C; Díaz F; Burgos FJ
    Transplant Proc; 2012 Nov; 44(9):2521-4. PubMed ID: 23146442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.